A Systematic Review and Metasynthesis of Hematopoietic Stem Cell Transplant (HSCT) Patient's Experiences of Long-Term Monitoring Clinics from the Patient's Perspective

This study aimed to synthesize all qualitative evidence on the experiences of hematopoietic stem cell transplant (HSCT) patients attending long-term monitoring clinics from their perspective. A systematic search of the literature was undertaken across 8 databases. The Critical Appraisal Skills Program was used to evaluate each study's quality. Confidence in the Evidence from Reviews of Qualitative Research was employed to assess confidence in each finding. Three themes from 4 qualitative studies were identified relating to patients’ experiences, “[It's] important to maintain a good relationship with the nurses and doctors,” “There's always the thing about the logistics,” and “Once you have cancer, you’re always thinking do I have it again?”. The findings suggest that HSCT patients’ experiences of long-term follow-up care clinics are influenced by the patient-provider relationship and the logistical set-up of monitoring practices, and weakly connected with fear of cancer recurrence. Future research is needed to understand the impact of each finding of this review, specifically in relation to patients’ country of residence to gain a greater understanding of their monitoring support needs.

[1]  S. Bhatia,et al.  Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Hicks,et al.  Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report. , 2021, JAMA oncology.

[3]  N. Kröger,et al.  One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors , 2021, Haematologica.

[4]  E. Holler,et al.  “This Graft-vs.-Host Disease Determines My Life. That's It.”—A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany , 2021, Frontiers in Public Health.

[5]  N. Kröger,et al.  Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years , 2021, Bone Marrow Transplantation.

[6]  R. Matin,et al.  “Is this the GVHD?” A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service , 2021, Health and Quality of Life Outcomes.

[7]  J. Byrne,et al.  Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 years , 2020, Bone Marrow Transplantation.

[8]  I. Kerridge,et al.  Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study. , 2020, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[9]  P. Warkentin.  Foundation for the Accreditation of Cellular Therapy , 2020, Definitions.

[10]  W. Ang,et al.  The haematopoietic stem cell transplant survivors’ sense of coherence about their experiences: a qualitative study , 2020, Supportive Care in Cancer.

[11]  S. Montoto,et al.  Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors , 2019, Bone Marrow Transplantation.

[12]  M. Perales,et al.  ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  Andrew Booth,et al.  Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series , 2018, Implementation Science.

[14]  W. Wood,et al.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  G. Basak,et al.  Provision of Long-Term Monitoring and Late Effects Services Following Hematopoietic Cell Transplantation (HCT): A Survey of European Programs By the Complications and Quality of Life Working Party of the EBMT , 2016 .

[16]  P. Butow,et al.  From normal response to clinical problem: definition and clinical features of fear of cancer recurrence , 2016, Supportive Care in Cancer.

[17]  J. Wardle,et al.  Health behaviours and fear of cancer recurrence in 10 969 colorectal cancer (CRC) patients , 2016, Psycho-oncology.

[18]  W Buylaert,et al.  Communication in healthcare: a narrative review of the literature and practical recommendations , 2015, International journal of clinical practice.

[19]  C. Aghajanian,et al.  A systematic review of ovarian cancer and fear of recurrence , 2015, Palliative and Supportive Care.

[20]  M. Rinck,et al.  Selective Attention and Fear of Cancer Recurrence in Breast Cancer Survivors , 2015, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[21]  F. Dobbels,et al.  Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study , 2014, Bone Marrow Transplantation.

[22]  K. Kuntz,et al.  Prevalence of hematopoietic cell transplant survivors in the United States. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  M. Suarez‐Almazor,et al.  Late effects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study , 2012, BMJ Supportive & Palliative Care.

[24]  J. Savard,et al.  Fear of cancer recurrence: specific profiles and nature of intrusive thoughts , 2010, Journal of cancer survivorship : research and practice.

[25]  J. Beaumont,et al.  The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  J. Wingard,et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Mar , 2006, Bone Marrow Transplantation.

[27]  J. Szer,et al.  Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New Zealand. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[28]  S. Pavletic,et al.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[29]  C. Maheu,et al.  Fear of cancer recurrence: A study of the experience of survivors of ovarian cancer. , 2017, Canadian oncology nursing journal = Revue canadienne de nursing oncologique.

[30]  A. Taft,et al.  Bmc Medical Research Methodology Open Access Methods for the Thematic Synthesis of Qualitative Research in Systematic Reviews , 2022 .